1. Academic Validation
  2. Posttranslational lysine 2-hydroxyisobutyrylation of human sperm tail proteins affects motility

Posttranslational lysine 2-hydroxyisobutyrylation of human sperm tail proteins affects motility

  • Hum Reprod. 2020 Mar 27;35(3):494-503. doi: 10.1093/humrep/dez296.
Yi-Min Cheng 1 Zhen Peng 1 2 Hou-Yang Chen 3 Ting-Ting Pan 1 Xiao-Nian Hu 1 Fang Wang 1 Tao Luo 1
Affiliations

Affiliations

  • 1 Institute of Life Science and School of Life Science, Nanchang University, Nanchang, Jiangxi 330031, PR China.
  • 2 Department of Pharmacy, the First People's Hospital of Yichun City in Jiangxi Province, Yichun 336000, China.
  • 3 Reproductive Medical Center, Jiangxi Provincial Maternal and Child Health Hospital, Nanchang 330006, PR China.
Abstract

Study question: Does lysine 2-hydroxyisobutyrylation, a newly identified protein posttranslational modification (PTM), occur in human sperm and affect human sperm function?

Summary answer: Lysine 2-hydroxyisobutyrylation mainly occurs in human sperm tail proteins, and excessive lysine 2-hydroxyisobutyrylation affects human sperm motility.

What is known already: PTM is regarded as an important pathway in regulating sperm function since mature sperm are almost transcriptionally silent. However, only phosphorylation was extensively studied in mature sperm to date. Lysine 2-hydroxyisobutyrylation, a newly characterised PTM, is broadly conserved in both eukaryotic and prokaryotic cells. Although histone lysine 2-hydroxyisobutyrylation has been shown to be associated with active gene expression in spermatogenic cells, the presence, regulatory elements and function of lysine 2-hydroxyisobutyrylation have not been characterised in mature sperm.

Study design, size, duration: Sperm samples were obtained from normozoospermic men and asthenozoospermic men who visited the reproductive medical centre at Jiangxi Provincial Maternal and Child Health Hospital, Nanchang, Jiangxi, China, between May 2017 and November 2018. In total, 58 normozoospermic men and 65 asthenozoospermic men were recruited to participate in this study.

Participants/Materials, setting, methods: Lysine 2-hydroxyisobutyrylation was examined using immunoblotting and immunofluorescence assays using a previously qualified pan anti-lysine 2-hydroxyisobutyrylation antibody. The immunofluorescence assay was imaged using super-resolution structured illumination microscopy. Sperm viability was examined by using the eosin staining method, and sperm motility parameters were assessed by computer-assisted sperm analysis. Sperm penetration ability was determined by evaluating the ability of the sperm to penetrate a 1% (w/v) methylcellulose solution. The level of intracellular adenosine triphosphate (ATP) was detected using a rapid bioluminescent ATP assay kit.

Main results and the role of chance: Lysine 2-hydroxyisobutyrylation was present in several proteins (20-100 kDa) mainly located in the tail of human sperm. Sperm lysine 2-hydroxyisobutyrylation was derived from 2-hydroxyisobutyrate (2-Hib) and was regulated by Acyltransferase P300 and nicotinamide adenine dinucleotide-dependent lysine deacylase sirtuins. Elevation of sperm lysine 2-hydroxyisobutyrylation by 2-Hib decreased total motility, progressive motility, penetration ability and ATP level of human sperm. Interestingly, the level of sperm lysine 2-hydroxyisobutyrylation was higher in asthenozoospermic men than that in normozoospermic men and was negatively correlated with the progressive motility of human sperm. Furthermore, high levels of lysine 2-hydroxyisobutyrylation in asthenozoospermic men accompanied decreased ATP levels.

Limitations, reasons for caution: Although the present study indicated the involvement of sperm lysine 2-hydroxyisobutyrylation in regulating human sperm motility, the underlying mechanism needs to be further illustrated.

Wider implications of the findings: The findings of this study provide insight into the novel role of lysine 2-hydroxyisobutyrylation in human sperm and suggest that abnormality of sperm lysine 2-hydroxyisobutyrylation may be one of the causes for asthenozoospermia.

Study funding/competing interest(s): National Natural Science Foundation of China (81771644 to T.L. and 81871207 to H.C.); Natural Science Foundation of Jiangxi province (20171ACB21006). The authors have no conflicts of interest to declare.

Keywords

adenosine triphosphate; asthenozoospermia; lysine 2-hydroxyisobutyrylation; protein posttranslational modifications; sperm motility.

Figures
Products